Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
11
|
pubmed:dateCreated |
1991-12-31
|
pubmed:abstractText |
Synthesis, radioligand binding, and pharmacologic activities of a series of muscarinic receptor ligands including and related to azaprophen (6-methyl-6-azabicyclo[3.2.1]octan-3 alpha-ol 2,2-diphenylpropionate, 1) have been measured to determine activity and selectivity for muscarinic receptor subtypes. Pharmacologic affinities of antagonists were determined as pA2 values for antagonism of methacholine-induced tension responses in guinea pig ileum. Binding affinities were measured by competition against [3H]QNB binding in guinea pig ileum, rat heart and brain, and m1- or m3-transfected Chinese hamster ovary (CHO) cells. The efficacies of muscarinic agonists in brain were determined by the ratio of binding affinities against [3H]QNB or [3H]NMS and [3H]oxotremorine-M ([3H]Oxo-M). Nine muscarinic antagonists, including azaprophen, did not discriminate significantly between the subtypes of muscarinic receptors. KI values for receptor binding for azaprophen (1) were between 8.81 x 10(-11) and 4.72 x 10(-10) M in ileum, heart, brain, and m1- or m3-transfected CHO cells. The alpha- and beta-benzilate esters 5 and 6 are as potent as azaprophen, and diphenylacetate esters 3 and 4 and N-(6)-benzyl alpha-isomer 7 are less potent than azaprophen. Significant stereoselectivity was exhibited with (+)-azaprophen being approximately 200 times more potent than the (-)-enantiomers and the 3 beta-ol isomer 2 being ca. 50 times less potent than azaprophen in all systems. A molecular modeling-molecular mechanics study was conducted to account for the difference. Putative muscarinic agonists (analogues and isomers of 6-methyl-6-azabicyclo[3.2.1]octan-3-ol acetate) did not discriminate muscarinic receptor subtypes with KI values between 2.77 x 10(-6) and 4.33 x 10(-5) M without significant stereoselectivity in the systems examined. The most active analogue was (1R,3R,5S)-6-[1(R)-phenylethyl]-6-azabicyclo[3.2.1]octan-3 alpha-ol acetate. However, efficacies of these putative agonists were in general very low.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
0022-2623
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
34
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
3164-71
|
pubmed:dateRevised |
2007-11-14
|
pubmed:meshHeading |
pubmed-meshheading:1956033-Animals,
pubmed-meshheading:1956033-Binding, Competitive,
pubmed-meshheading:1956033-Cricetinae,
pubmed-meshheading:1956033-Cricetulus,
pubmed-meshheading:1956033-Female,
pubmed-meshheading:1956033-Guinea Pigs,
pubmed-meshheading:1956033-Male,
pubmed-meshheading:1956033-Models, Molecular,
pubmed-meshheading:1956033-Muscle, Smooth,
pubmed-meshheading:1956033-Radioligand Assay,
pubmed-meshheading:1956033-Rats,
pubmed-meshheading:1956033-Rats, Inbred Strains,
pubmed-meshheading:1956033-Receptors, Muscarinic,
pubmed-meshheading:1956033-Stereoisomerism,
pubmed-meshheading:1956033-Structure-Activity Relationship,
pubmed-meshheading:1956033-Tropanes
|
pubmed:year |
1991
|
pubmed:articleTitle |
Synthesis, molecular modeling studies, and muscarinic receptor activity of azaprophen analogues.
|
pubmed:affiliation |
Research Triangle Institute, Research Triangle Park, North Carolina 27709.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.
|